Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Sukean Pharmaceutical is a specialized pharmaceutical company based in Haining, China, operating as a wholly-owned subsidiary of Zhejiang Jingxin Pharmaceutical. The company is primarily engaged in the research, development, and industrialization of high-end chemical medicines, including both Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Its core therapeutic focus aligns with its parent company, targeting cardiovascular diseases, central nervous system disorders, and digestive health. Sukean maintains advanced manufacturing facilities that adhere to international GMP standards, supporting the large-scale production of key products such as statins and antidepressants. The company plays a critical role in the integrated supply chain and production capacity of the Jingxin Pharmaceutical group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江苏可安药业.